Genmab (GMAB)
(Delayed Data from NSDQ)
$27.46 USD
-0.06 (-0.22%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $27.47 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC11/6/24 |
---|---|
Current Quarter | 0.30 |
EPS Last Quarter | 0.22 |
Last EPS Surprise | -24.14% |
ABR | 2.28 |
Earnings ESP
|
3.33% |
---|---|
Current Year | 1.21 |
Next Year | 1.45 |
EPS (TTM) | 1.21 |
P/E (F1) | 22.76 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 807.93M | 838.82M | 3.13B | 3.68B |
# of Estimates | 4 | 4 | 5 | 6 |
High Estimate | 874.07M | 895.35M | 3.19B | 3.84B |
Low Estimate | 718.33M | 730.61M | 3.05B | 3.48B |
Year ago Sales | 692.80M | 675.29M | 2.39B | 3.13B |
Year over Year Growth Est. | 16.62% | 24.22% | 30.90% | 17.50% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.30 | 0.30 | 1.21 | 1.45 |
# of Estimates | 7 | 6 | 9 | 8 |
Most Recent Consensus | 0.35 | 0.41 | 1.39 | 1.58 |
High Estimate | 0.35 | 0.41 | 1.40 | 1.64 |
Low Estimate | 0.25 | 0.18 | 1.00 | 1.27 |
Year ago EPS | 0.47 | 0.36 | 1.18 | 1.21 |
Year over Year Growth Est. | -36.17% | -16.67% | 2.54% | 20.24% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 2 | 2 | 5 | 3 |
Up Last 60 Days | 2 | 2 | 5 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 2 |
Down Last 60 Days | 1 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.30 | 0.30 | 1.21 | 1.45 |
7 Days Ago | 0.30 | 0.30 | 1.21 | 1.49 |
30 Days Ago | 0.28 | 0.29 | 1.13 | 1.41 |
60 Days Ago | 0.27 | 0.28 | 1.11 | 1.41 |
90 Days Ago | 0.27 | 0.28 | 1.11 | 1.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.31 | 0.32 | 1.26 | 1.48 |
Zacks Consensus Estimate | 0.30 | 0.30 | 1.21 | 1.45 |
Earnings ESP | 3.33% | 6.32% | 3.95% | 1.80% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.22 | 0.16 | 0.36 | 0.47 | NA |
Estimate | 0.29 | 0.16 | 0.34 | 0.34 | NA |
Difference | -0.07 | 0.00 | 0.02 | 0.13 | 0.02 |
Surprise | -24.14% | 0.00% | 5.88% | 38.24% | 5.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more